Jaap Koopman

Allianz Capital Partners GmbH (ACP) is part of the private equity arm and a wholly-owned subsidiary of Allianz Alternative Assets Holding GmbH which in turn is a subsidiary of Allianz SE (FR: ALV; NYSE: AZ), a global leader in insurance and financial services. ACP was established in 1998 and is headquartered in Munich. The firm specializes in direct equity investment in unlisted companies. Their fellow subsidiary APEP-Allianz Private Equity Partners is primarily involved in indirect investments through private equity funds of funds. ACP invests capital exclusively on behalf of the life and non-life insurance companies of the Allianz Group.

Arthur Andersen LLP used to provide accounting services. It was also into consulting services for clients that operate businesses throughout the United States and around the world. Arthur Andersen was founded in 1913 and was headquartered in Chicago, IL.

Ridley Terminals, Inc. owns and operates a marine bulk handling terminal. It offers railcar unloading, product storage, and vessel loading services for the export of metallurgical and thermal coal and petroleum coke. The company was founded in 1983 and is headquartered in Prince Rupert, Canada.

NanoBridge Partners is a private equity firm located in New York City. The firm is a subsidiary of Edgewood Holdings LLC

Lotus AG is an independent asset management firm headquartered in Grünwald, Germany. The firm provides investment advisory services to individual and institutional clients.

ShawMan Software Pvt Ltd. operates as a boutique software product development company. It offers online ordering; property management system; sales and and catering; notification services; smart debit card; whitelabel app; and club management systems. The firm serves the hospitality, food service, and leisure industries. The company was founded on April 5, 2007 and is headquartered in Mumbai, India.

Park Vale Capital Ltd. (Park Vale) is an independent alternative asset management firm headquartered in London, UK. The firm was founded by Phil Cooper and Katherine Priestley in 2005 as Lincoln Vale LLP. Park Vale manages assets on behalf of foundations and private wealth clients.

Dietsmann Technologies SA engages in the provision of operation and maintenance services. The company was founded on October 28, 1992 and is headquartered in Salies-du-Salat, France.

Part of Sijthoff Media Groep BV, Netherlands Institute of Registered Accountants is a professional organization set by law for accountants in the Netherlands. The company is based in Amsterdam, the Netherlands. The Dutch company aims to promote the good professional practice of all its members and monitors the quality of the accountancy profession. With the accountancy profession act, the company has transformed into a new organizational form, focusing on pro-activity, quality, and a different governance structure. Netherlands Institute of Registered Accountants was acquired by Sijthoff Media Groep BV on July 01, 2021.

Chiron Partners LLC provides merchant banking and strategic advisory services. It offers merchant banking and advisory, mergers and acquisition, private placement, and debt restructure services. It also provides specialized services such as valuation reports, feasibility studies, due diligence, operating advisory, financial management, and business development. The company was founded by Mark David Sanor on November 1, 2010 and is headquartered in New York, NY.

Meyer Bergman Ltd. provides real estate investment and fund management services. It engages in the development, repositioning ,and asset management of under-utilized or undermanaged retail assets including shopping centers and high street shops in downtown and out-of-town locations. The company was founded by Markus S. Meijer on August 1, 2002 and is headquartered in London, the United Kingdom.

ReneSola America, Inc. engages in the manufacture and supply of green energy products. It produces led lighting lamps and fixtures, and photovoltaic modules and inverters. The company was founded on March 6, 2012 and is headquartered in Fremont, CA.

Gerlin NV operates as Closed-End Investment Trust. The company is headquartered in Maarsbergen, the Netherlands.

Dietsmann NV engages in maintenance of production plant in the oil and gas, power and mining industries. Its services include maintenance engineering, operation and maintenance services, electrical and instrumentation engineering and construction, and technical assistance services. The company was founded by Peter R. G. Kütemann in 1977 and is headquartered in Breda, the Netherlands.

CropDesign NV develops traits for cereal crops. It delivers agronomic traits for the global commercial seed markets. The firm focuses on enhancing grain yield in crops such as corn and rice, and increasing biomass of energy crops. Its platform, TraitMill, lows evaluating the effect of genes on the performance of plants under different growing conditions, including drought and low nutrient stress. The company was founded in 1998 and is headquartered in Zwijnaarde, Blgium.

PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

Ogeda SA discovers and develops small molecule drugs. It develops NK3 antagonists for the treatment of hormone-dependent pathologies in the field of Women's Health. The company was founded in 1994 and is headquartered in Gosselies, Spain.

Vesalius Biocapital Partners SARL (Vesalius Biocapital Partners) is an independent venture capital firm founded in 2007 by Stéphane Verdood. The firm is headquartered in Luxembourg.

Apitope Technology (Bristol) Ltd. is a European biotech company developing therapeutic vaccines for treating autoimmune and allergic diseases, including multiple sclerosis, Type 1 diabetes, Graves' disease, allergies and organ transplant rejection. The team at Apitope is developing potential therapies intended to selectively treat the underlying cause of a range of autoimmune diseases rather than simply treat the disease symptoms or non-specifically suppress the whole immune system. Apitope's approach is based on well-established scientific evidence published in leading scientific journals showing that soluble, synthetic peptides can selectively suppress abnormal immune responses and reinstate the normal immune balance and thereby, tolerance. The firm's strategy is to position itself as a significant player in the therapeutic peptide space and make it a partner of choice for pharmaceutical companies keen to develop disease modifiers for autoimmune conditions. It has a highly experienced senior management team, with a proven track record in discovering and developing innovative compounds. The company's lead product candidate is under investigation for the potential treatment of multiple sclerosis and is currently in Phase I clinical development. It is partnered with Merck-Serono (a division of Merck KGaA, Darmstadt, Germany), one of the leading companies in the development and marketing of MS therapies.